ESTIMATION OF G-CSF EFFECTIVENESS IN REDUCING NEUTROPENIA HOSPITALIZATION AMONG NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS TREATED WITH ANTHRACYCLINE-BASED CHEMOTHERAPY

被引：0
|
作者：
Pan, X. [1 ]
Brooks, J. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72101-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A25 / A25
页数：1
相关论文
共 50 条
  • [1] PREDICTORS OF G-CSF PROPHYLAXIS IN THE FIRST CYCLE OF CHEMOTHERAPY FOR FEBRILE NEUTROPENIA IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
    Lugtenburg, P.
    Asubonteng, J.
    DeCosta, L.
    Szabo, Z.
    Page, J. H.
    Wetten, S.
    HAEMATOLOGICA, 2014, 99 : 196 - 196
  • [2] Risk factors for febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) treated with anthracycline-based chemotherapy
    Morrison, V. A.
    Weller, E. A.
    Habermann, T. M.
    Li, S.
    Horning, S. J.
    Fisher, R. I.
    Peterson, B. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S70 - S70
  • [3] Cost-effectiveness analysis of G-CSF in elderly patients with aggressive non-Hodgkin's lymphoma (NHL) receiving CHOP
    Lyman, GH
    Cosler, LE
    VALUE IN HEALTH, 2006, 9 (03) : A107 - A107
  • [4] Predictors of G-CSF Prophylaxis in the First Cycle of Chemotherapy in Non-Hodgkin's Lymphoma Patients
    Asubonteng, Julius
    Wetten, Sally
    Lugtenburg, Pieternella J.
    DeCosta, Lucy
    Szabo, Zsolt
    Page, John H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 60 - 61
  • [5] Evaluating Diastolic Function by Echocardiography in a Prospective Cohort of Patients with Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL) Who Received Anthracycline-Based Chemotherapy
    Tawfiq, Reema
    Boddicker, Nicholas
    Martinez, Juan Quintero
    Cordova, Sandra
    Alam, Md Mashiul
    Cerhan, James
    Herrmann, Joerg
    Thompson, Carrie A.
    Villarraga, Hector R.
    CIRCULATION, 2021, 144
  • [6] The effect of G-CSF after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection
    Navarro, JT
    Ribera, JM
    GomezEspuch, J
    Feliu, E
    MEDICINA CLINICA, 1996, 107 (03): : 118 - 119
  • [7] Clinical factors associated with charges for neutropenia hospitalization among newly diagnosed non-Hodgkin's lymphoma patients treated with chemotherapy.
    Brooks, JM
    Klepser, DG
    Chrischilles, EA
    Voelker, MD
    Chen-Hardee, SS
    Scott, SD
    Link, B
    Delgado, DJ
    BLOOD, 2002, 100 (11) : 501B - 501B
  • [8] Oral combination chemotherapy (CT) in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma (NHL)
    Remick, SC
    Bibighaus, MR
    Reddy, M
    Haase, RF
    Nazeer, T
    Kumar, N
    Anand, PK
    Ramnes, CR
    Pearce, TP
    Mastrianni, DM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 86 - 86
  • [9] Patterns of Granulocyte Colony-Stimulating Factor (G-CSF) Use in Elderly Patients with Non-Hodgkin's Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy
    Page, John H.
    Solid, Craig
    Chia, Victoria M.
    Blaes, Anne Hudson
    Barron, Richard L.
    Choi, Mi Rim
    Arneson, Thomas J.
    BLOOD, 2012, 120 (21)
  • [10] G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin's lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy
    Vitolo, Umberto
    Angrili, Francesco
    DeCosta, Lucy
    Wetten, Sally
    Federico, Massimo
    MEDICAL ONCOLOGY, 2016, 33 (12)
12345